Iso-Partricin, an Aromatic Analogue of Amphotericin B: How Shining Light on Old Drugs Might Help Create New Ones
by
Paweł Szczeblewski
1, 
Justyna Górska
1,
Witold Andrałojć
2,
Patryk Janke
1,
Karolina Wąsik
1 and
Tomasz Laskowski
1,* 1
Department of Pharmaceutical Technology and Biochemistry and BioTechMed Centre, Faculty of Chemistry, Gdańsk University of Technology, Gabriela Narutowicza Str. 11/12, 80-233 Gdańsk, Poland
2
Institute of Bioorganic Chemistry, Polish Academy of Sciences, Zygmunta Noskowskiego Str. 12/14, 61-704 Poznań, Poland
*
Author to whom correspondence should be addressed.
Antibiotics 2021, 10(9), 1102; https://doi.org/10.3390/antibiotics10091102
Submission received: 17 August 2021
/
Revised: 2 September 2021
/
Accepted: 10 September 2021
/
Published: 13 September 2021
(This article belongs to the Section The Global Need for Effective Antibiotics)
Abstract
:Partricin is a heptaene macrolide antibiotic complex that exhibits exceptional antifungal activity, yet poor selective toxicity, in the pathogen/host system. It consists of two compounds, namely partricin A and B, and both of these molecules incorporate two cis-type bonds within their heptaenic chromophores: 28Z and 30Z. In this contribution, we have proven that partricins are susceptible to a chromophore-straightening photoisomerization process. The occurring 28Z→28E and 30Z→30E switches are irreversible in given conditions, and they are the only structural changes observed during the experiment. The obtained all-trans partricin’s derivatives, namely iso-partricins A and B, exhibit very promising features, potentially resulting in the improvement of their selective toxicity.
1. Introduction
Among several groups of clinically used antifungal antibiotics, polyene macrolides should be regarded as the most versatile and promising family of fungicidal agents. They exhibit most of the features of a mythical “ideal drug”, with two major disadvantages depriving them of their rightful place on top of the antifungal pantheon: (1) poor bioavailability, resulting from poor solubility in water; and (2) relatively poor pathogen/host selective toxicity [1]. Although the former problem may be easily overcome by a proper formulation of a drug, the latter is directly related to the molecular mode of action of clinically used polyene macrolides; thus, they require rational modifications to their chemical structure.
The highest antifungal activity is attributed to the polyene macrolides belonging to the heptaenic group. This family may be divided into two subgroups: (1) non-aromatic all-trans heptaenes, with amphotericin B (AmB) being “the big star” and still considered to be a golden standard in treatment of systemic fungal infections, and (2) aromatic heptaenes (AHs), incorporating two cis-type double bonds in their heptaenic chromophores and an extra structural feature: an alkyl-aromatic side chain, attached to the major macrolactone ring [2,3]. Members of the latter subgroup exhibit up to two orders of magnitude higher antifungal activity than AmB [4], yet none of them is currently recommended for clinical use in treatment of internal mycoses, mainly due to their especially poor selective toxicity and severe side effects.
AHs are often misrepresented in the literature, as the all-trans compounds, yet none of the Ahs—found in nature to this date, that is—exhibits such a geometry of the chromophore. The most widely known representative of AHs, the candicidin complex (syn. levorin, ascosin, produced by Streptomyces griseus), consists of three major components and each of them incorporates two cis-type bonds, i.e., 26Z and 28Z [5]. The other member of the AH family, partricin complex (syn. aureofacin, produced by Streptomyces aureofaciens) involves two compounds, differentiated solely by one methyl group at the end of the side chain [6,7]. Both of these molecules also incorporate two cis-type bonds, yet in different positions, i.e., 28Z and 30Z (Figure 1) [8,9,10]. Members of the partricin complex, partricin A (syn. gedamycin) and partricin B (syn. vacidin) contain more oxygen functions in C1-C15 fragment than the candicidins [5], which probably translates to slightly higher antifungal activity due to enhanced rigidity of partricin’s macrolactone ring.
Although partricin is not currently used as a weapon against systemic mycoses, methyl ester of partricin, aka mepartricin (Ipertrofan and Tricandil), was proven to be useful in treatment of benign prostatic hyperplasia and chronic nonbacterial prostatitis/pelvic pain syndrome [11,12,13,14]. Similar to all members of the heptaenic family, mepartricin effectively binds to steroids, and this feature is considered to be the foundation of the therapeutic effect [15].
Previously, we have shown that the main candicidin, candicidin D [16], while exposed to UV–VIS radiation, undergoes photochemical isomerization reaction, which results in straightening of the heptaenic chromophore to the AmB-type (all-trans) geometry [17]. This process is irreversible in the given conditions and it is the only structural change occurring during the experiment, assuming that the radiation dose and the time of exposure are fairly optimized. Since partricins exhibit different geometry of the heptaenic chromophore [8,10], in this study, we have settled whether their exposure to UV–VIS radiation would produce similar results to the ones observed for candicidin D. Straightening of the heptaenic chromophore to the all-trans geometry should be regarded as the first step in a long journey, leading to significant improvement of AHs’ selective toxicity and, thus, creation of a better drug than the current standard, amphotericin B.
2. Results
2.1. Shedding A New Light to Old Matters
As we stated before [5], there are many inconsistencies in the literature regarding data on aromatic heptaene macrolide antibiotic complexes. Previously, we have solved the candicidin case [17]. Going on with our mission to put these matters in order, we have also confirmed that the names “partricin” and “aureofacin” should be used as synonyms, since they refer to the same antibiotic complex [18]. As we postulated earlier, some of the previous confusions might have risen from the photochemical isomerization phenomenon of the partricin complex, which we decided to examine in this contribution.
Similarly to the procedure applied in case of the candicidin complex, a simple experiment was conducted [17]. Two identical solutions of partricin complex were prepared: one stored in darkness for 24 h (control) and the second one, simultaneously stored and unguarded from direct daylight. As can be seen in Figure 2, observed number of major components of the partricin complex, illuminated with daylight (red line), has doubled in comparison to the control sample (blue line). Partricins A and B were partially transformed into their isomers, exhibiting the very same molecular masses, yet responding with significantly altered UV–VIS spectra. Since the heptaenic chromophore of polyene macrolides is by far the major contributor to their electronic spectra, it was obvious that structural changes—at least those registered by photonic absorption—must have occurred in this region.
UV–VIS spectra of the native partricins incorporate three absorption maxima at λ1 = 360 nm, λ2 = 378 nm and λ3 = 401 nm, with the one at the medium (λ2) being of highest intensity (Figure 2). Such an image is generally attributed to a heptaenic system that contains several Z double bonds within [19]. While the positions and number of the Z bonds might not be directly extracted from the antibiotics’ electronic spectra, previous studies on partricin A and partricin B have proven that those molecules contain two cis-type double bonds at positions 28 and 30 (Figure 1) [8,10].
The absorption maxima observed for iso-partricins A and B were subjects to bathochromic shifts, manifesting at λ1* = 364 nm, λ2* = 384 nm and λ3* = 407 nm. Moreover, the relative intensities of λ2* and λ3* were inversed in relation to the native compounds (Figure 2). This shape of an electronic spectrum has been previously demonstrated to indicate to the all-trans type of heptaenic chromophore, identical to the one of amphotericin B [3]. However, this testimony could not be accepted as a direct structural proof and, therefore, required further verification. Additionally, the remaining structural regions of the iso-molecules must have also been tested for other potential light-induced constitutional alterations. Thus, 1H NMR was selected as a major tool for the following structural studies.
2.2. NMR Studies on Iso-Partricin A and B
The native partricin complex was derivatized into its N-acetyl methyl ester via series of simple reactions. This procedure, developed at our department, is a well-established approach for the elucidation of constitution and/or stereochemistry of polyene macrolides, using NMR techniques [5,16,20,21,22], and, as an option, could be followed in order to facilitate purification of studied antibiotic molecules and enhance their solubility in standard NMR solvents. Later, the resulting methyl ester of N-acetylpartricin (referred to as partricin*) was exposed to moderate UV–VIS radiation of λ = 365 nm. The chosen reaction wavelength was identical to the one that produced the best results for candicidin D and was not optimized in this study [17]. The progress of a photochemical reaction was traced by using continuous UV–VIS spectra. When further irradiation caused no visible changes in the electronic spectra, methyl ester of N-acetyl-iso-partricin A (referred to as iso-partricin A*) and methyl ester of N-acetyl-iso-partricin B (aka iso-partricin B*) were isolated and purified by using HPLC.
Iso-partricin A* and iso-partricin B* molecules were subjects to a standard set of 2D NMR experiments, consisting of DQF-COSY, TOCSY, HSQC, HMBC and ROESY spectra (please consult Figures S1–S12) [5,16,20,21,22,23,24,25,26]. DQF-COSY, TOCSY and HSQC spectra were used to trace proton–proton and proton–carbon connectivities within isolated protonic spin systems, while HMBC and ROESY experiments enabled gluing all the pieces together, due to long ranged heteronuclear couplings and structurally conclusive dipolar couplings between protons. Finally, DQF-COSY and ROESY spectra allowed the definition of the stereostructure of the studied compounds, including absolute configurations of almost all stereogenic centers within the molecules and—most importantly—the geometries of iso-partricin’s A* and iso-partricin’s B* chromophores.
Detailed NMR studies revealed that, in contrary to the NMR data on the partricin A and partricin B methoxycarbonylmethylamide derivatives [8,9,10], all the 3JH,H coupling constants within the double bonds were no lower than 15.1 Hz and no higher than 15.6 Hz, thus determining the E geometry of the entire chromophore systems. The chemical shifts of all the olefinic carbons (C22–C35) ranged between 130 and 137 ppm, which strongly suggested the E geometries of all the double bonds within the chromophores, since no shielding γ-effects were observed for the C27/C30 and C29/C32 pairs [9,16,22]. Moreover, rich sets of ROEs between the protons of the C2–C13 and C22–C35 fragments were recorded (Figure 3), as well as two uninterrupted ROE pathways, incorporating even- and odd-numbered olefinic protons (see Appendix A section, Table A1). The stereostructural requirements for all those dipolar couplings might be met only in case of straightening of the heptaenic chromophores to the all-trans geometries. Additionally, some of the vicinal proton–proton coupling constants within the C2–C9 fragments have changed in comparison to the cis–trans derivatives [9,10], which should be attributed to the alteration of the flexibility of the macrolactone ring systems, resulting from changes in the geometry of the chromophores.
No other constitutional and/or stereochemical changes in iso-partricin A* and iso-partricin B* were found in comparison to the native compounds. Thus, we have proven that 28Z→28E and 30Z→30E switches are the only chemical changes of partricins’ structures, occurring as a result of moderate UV–VIS irradiation.
More detailed information on the 1 H and 13 C resonances of iso-partricin A* and iso-partricin B* is given in Table A1.
3. Discussion
The work presented in this manuscript, along with the previously conducted studies on candicidin D and its all-trans isomer [17], have proven that the native aromatic heptaene macrolide antifungal antibiotics are in fact susceptible to a chromophore-straightening photoisomerization process, regardless of the positions of the Z double bonds within their original chromophores. The resulting transformations are irreversible in the given experimental conditions, yet it must be noted that the yield of the whole process is below 100%, since the welcomed structural changes are in fact competed by the antibiotics’ degradation. The latter fact presumably creates a space for further optimization of the production of the AHs’ isoforms.
The all-trans aromatic heptaenes (especially the iso-partricins, exhibiting high resemblance of their polyol chains to the one of AmB) might be, therefore, considered as aromatic analogues of amphotericin B—the only polyene macrolide antibiotic used clinically in treatment of systemic fungal infections. Our preliminary results on in vitro biological activity of iso-candicidin D, iso-partricin A and iso-partricin B have strongly suggested that fungicidal activity of the all-trans isoforms remains comparable to the native molecules, thus still exceeding the one of AmB by almost two orders of magnitude. Meanwhile, the hemolytic activity of iso-AHs has been substantially reduced in comparison to the native cis–trans forms. The calculated selective toxicity indexes (STIs), which relate to the EH50 to MIC ratio, were equal to > 20 and 19.28 for iso-partricin A and iso-partricin B, respectively. Initial assessments have therefore demonstrated that both iso-partricins were more selective than AmB (STI = 13.84), mainly due to the lowered hemolytic activity. For more details on biological activity of iso-partricins, along with computational studies on their interactions with membrane sterols, please consult [27].
In the end, the in vitro selective toxicity index of AHs seems to benefit a lot from the straightening of their heptaenic chromophores, which encourages us to have high hopes, regarding following studies on these compounds and their further development.
4. Materials and Methods
4.1. Partricin Complex
The crude partricin complex was obtained by extraction with n-butanol from fermentative broth of Streptomyces aureofaciens NRRL 3878 in the Department of Pharmaceutical Technology and Biochemistry, Gdańsk University of Technology (Gdańsk, Poland). The volume of resulting solution was reduced by evaporation under reduced pressure and centrifuged. The precipitate was washed several times with acetone and dry ethyl ether and dried under reduced pressure. The crude antibiotic complexes were then purified by using the procedure described in patent no. 83,710 [28].
4.2. Synthesis of Methyl Ester of 3′-N-Acetylpartricin Complex (Partricin*)
4.3. Photochemical Cis−Trans Isomerization of Partricin*
The partricin* complex was dissolved in a 95% methanol/5% water solvent system to a concentration of 1 mg/mL. While gently stirring, one liter of this solution (~2 cm depth) was then irradiated with two long-wavelength UV lamps (λ = 365 nm, 8 W) for ca. 1 h. The reaction vessel was placed in the dark, at room temperature. The progress of the photochemical isomerization reaction was monitored by using UV−VIS spectroscopy and RP-HPLC analysis. The RP-HPLC analysis conditions were as follows: column, Luna 100 C18 (2) (150 × 4.6 mm, 5 µm); mobile phase composition, 38% acetonitrile/62% ammonium acetate buffer (5.5 mmol, pH = 4.5), v/v; flow rate, 1 mL/min; detection at 378 nm; room temperature.
4.4. Isolation of the Methyl Esters of 3′-N-Acetyl-Iso-Partricin A and B (Iso-Partricin A* and Iso-Partricin B*)
The isolation of the iso-partricin A* and iso-partricin B* from the partricin* complex was performed by means of semi-preparative HPLC on a Merck–Hitachi apparatus L-6200A, equipped with Merck–Hitachi L-4250 UV–VIS detector. The separation conditions were as follows: column LiChrosorb Si60 (250 mm × 10 mm, 7 μm), mobile phase composition: chloroform/methanol/water (5:0.4:0.035, v/v/v); flow rate 6.25 mL/min; detection at 407 nm, room temperature. A sample of 10 mg/mL (dissolved in the mobile phase) in a volume of 0.625 mL was injected. The retention time was 18 min and 29 min for iso-partricin A* and iso-partricin B*, respectively. The semi-preparative HPLC separation was performed several times, yielding 7 mg of the iso-partricin A* and 8 mg of the iso-partricin B*.
4.5. NMR Experiments
The NMR spectra were recorded with a Bruker Avance III HD 700 MHz spectrometer equipped with QCI CryoProbe in solvent system pyridine-d5-methanol-d4, 9:1 (v/v) at 25 °C with a sample concentration of 15 mg/mL. Chemical shifts were reported in δ (ppm) units, using 1H residual resonance from pyridine-d5 (7.19 ppm) as internal standard. The 1D 1 H NMR spectra were collected with digital resolution of 0.5 Hz. The 1 H 90° pulse length was 7.0 µs.
Two-dimensional 1H spectra were measured in the phase-sensitive mode with a spectral width of 7704 Hz.
The DQF-COSY spectra were acquired in a 4096 × 512 matrix with 32 accumulations per increment and were processed in a 4K × 2K matrix.
The TOCSY spectra were acquired with a mix time of 60 ms in a 2048 × 512 matrix with 32 accumulations per increment in a 2K × 1K matrix.
The ROESY spectra were acquired with a mix time of 300 ms in a 2048 × 512 matrix with 64 accumulations per increment in a 2K × 1K matrix.
HSQC and HMBC experiments were performed with pulse field gradients.
The edited HSQC spectra were acquired in the phase-sensitive mode with 1J(CH) set to 140 Hz. The spectral windows for 1H and 13 C axes were 7716 and 29,177 Hz, respectively. The data were collected with 64 accumulations per increment in a 2048 × 256 matrix and processed in a 2K × 1K matrix.
The HMBC spectra were acquired in absolute value mode with nJ(CH) set to 9 Hz. The spectral windows for 1H and 13 C axes were 7716 and 40,515 Hz, respectively. The data were collected with 192 accumulations per increment in a 2048 × 256 matrix and processed in a 2K × 1K matrix.
Supplementary Materials
The following are available online at https://www.mdpi.com/article/10.3390/antibiotics10091102/s1. Figure S1: The 1 H NMR spectrum of iso-partricin A. Figure S2: The 1 H NMR spectrum of iso-partricin B. Figure S3: The DQF-COSY spectrum of iso-partricin A. Figure S4: The DQF-COSY spectrum of iso-partricin B. Figure S5: The TOCSY spectrum of iso-partricin A. Figure S6: The TOCSY spectrum of iso-partricin B. Figure S7: The ROESY spectrum of iso-partricin A. Figure S8: The ROESY spectrum of iso-partricin B. Figure S9: Edited 1 H-13 C HSQC spectrum of iso-partricin A. Figure S10: The 1 H-13 C HMBC spectrum of iso-partricin A. Figure S11: Edited 1H-13C HSQC spectrum of iso-partricin B. Figure S12: The 1H-13C HMBC spectrum of iso-partricin B, Figure S13: HPLC-DAD-ESIMS chromatogram of isolated iso-partricin A. Figure S14: HPLC-DAD-ESIMS chromatogram of isolated iso-partricin B.
Author Contributions
Conceptualization, P.S. and T.L.; methodology, P.S., W.A. and T.L.; formal analysis, P.S., J.G., P.J., K.W. and T.L.; investigation, P.S., J.G., P.J., K.W. and T.L.; resources, P.J. and K.W.; writing—original draft preparation, P.S. and T.L.; writing—review and editing, J.G. and W.A.; visualization, P.S., J.G., W.A. and T.L. All authors have read and agreed to the published version of the manuscript.
Funding
This research was funded by Polish National Science Centre, grant number UMO-2016/23/B/NZ7/01223.
Institutional Review Board Statement
Not applicable.
Informed Consent Statement
Not applicable.
Data Availability Statement
The data presented in this study, including high resolution NMR spectra, are available on request from the corresponding author.
Conflicts of Interest
The authors declare no conflict of interest.
Appendix A
Table A1.
1H and 13C NMR spectroscopic data for iso-partricin A* and B* (700 MHz, C6D5N/CD3OD (9:1, v/v)). In every column, the letter A stands for spectroscopic data for iso-partricin A*, and the letter B stands for the analogous value for iso-partricin B*, whereas no letter given means that the presented data are identical for both antibiotics.
Table A1.
1H and 13C NMR spectroscopic data for iso-partricin A* and B* (700 MHz, C6D5N/CD3OD (9:1, v/v)). In every column, the letter A stands for spectroscopic data for iso-partricin A*, and the letter B stands for the analogous value for iso-partricin B*, whereas no letter given means that the presented data are identical for both antibiotics.
| Iso-Partricin A* and B* | |||||
|---|---|---|---|---|---|
| Position | δC, Type | δH | JH,H (Hz) | ROE Contacts | |
| Aglycone | |||||
| 1 | 170.85, | C | – | – | – |
| 2ab 1 | 43.48, | CH2 | 2.796 | ? (3) 1 | 3, 4a, 4b |
| 3 | 64.18, | CH | 4.863 | ? (2ab) 1, 8.8 (4a), 4.3 (4b) | 2ab, 4a, 4b, 34, Me38 |
| 4a | 51.05, | CH2 | 2.849 | 8.8 (3), 16.8 (4b) | 2ab, 3, 4b |
| 4b | 2.990 | 4.3 (3), 16.8 (4b) | 2ab, 3, 4a | ||
| 5 | 208.54, | C | – | – | – |
| 6a | 51.55, | CH2 | 2.632 | 16.4 (6b), 1.9 (7) | 4a, 6b, 7 |
| 6b | 2.874 | 16.4 (6a), 10.2 (7) | 4b, 6a, 7 | ||
| 7 | 67.79, | CH | 4.591 | 1.9 (6a), 10.2 (6b), 2.0 (8a), 9.7 (8b) | 6a, 6b, 8a, 8b, 9, 28 |
| 8a | 43.77, | CH2 | 1.529 | 2.0 (7), 13.8 (8b), 1.9 (9) | 6a, 7, 8b, 9, 10a |
| 8b | 1.732 | 9.7 (7), 13.8 (8b), 10.0 (9) | 6b, 7, 8a, 10b | ||
| 9 | 72.79, | CH | 4.269 | 1.9 (8a), 10.0 (8b), 2.2 (10a), 9.8 (10b) | 7, 8a, 10a, 11, 28 |
| 10a | 44.49, | CH2 | 1.465 | 2.2 (9), 14.1 (10b), 1.9 (11) | 8a, 9, 10b, 11, 12a |
| 10b | 1.670 | 9.8 (9), 14.1 (10a), 10.3 (11) | 8b, 10a, 11 | ||
| 11 | 73.02, | CH | 4.283 | 1.9 (10a), 10.3 (10b), 2.2 (12a), 9.4 (12b) | 9, 10a, 10b, 12a, 13, 24 |
| 12a | 44.31, | CH2 | 1.411 | 2.2 (11), 13.2 (12b), 1.8 (13) | 10a, 11, 12b, 13, 14a |
| 12b | 1.685 | 9.4 (11), 13.2 (12a), 10.1 (13) | 12a, 14b | ||
| 13 | 69.11, | CH | 4.746 | 1.8 (12a), 10.1 (12b), 2.0 (14a), 9.4 (14b) | 11, 12a, 14a, 22, 24 |
| 14a | 46.71, | CH2 | 1.755 | 2.0 (13), 14.6 (14b) | 12a, 13, 14b |
| 14b | 1.953 | 9.4 (13), 14.6 (14a) | 12b, 14a, 16b | ||
| 15 | 98.11, | C | – | – | – |
| 16a | 45.28, | CH2 | 1.743 | 12.4 (16b), 10.3 (17) | 16b, 18 |
| 16b | 2.543 | 12.4 (16a), 4.5 (17) | 14b, 16a, 17 | ||
| 17 | 66.34, | CH | 5.006 | 10.3 (16a), 4.5 (16b), 10.2 (18) | 16b, 18, 19 |
| 18 | 58.39, | CH | 2.853 | 10.2 (17), 10.1 (19) | 16a, 17, 19, 20a, 21 |
| 19 | 66.21, | CH | 5.049 | 10.1 (18), 10.5 (20a) | 17, 18, 20a, 20b, 22, 1′, 2′ |
| 20a | 37.86, | CH2 | 2.013 | 10.5 (19), 15.6 (20b) | 18, 19, 20b, 21 |
| 20b | 2.431 | 15.6 (20a), 9.6 (21) | 19, 20a, 21, 1′ | ||
| 21 | 75.91, | CH | 4.924 | 9.6 (20b), 9.2 (22) | 18, 20a, 20b, 22, 1′ |
| 22 | 136.89, | CH | 6.403 | 9.2 (21), 15.3 (23) | 13, 19, 21, 24 |
| 23 | 132.93, | CH | 6.449 | 15.3 (22), 11.1 (24) | 25 |
| 24 | 133.90, | CH | 6.674 | 11.1 (23), 15.4 (25) | 11, 13, 22, 26 |
| 25 | 130.00, | CH | 6.380 | 15.4 (24), 10.9 (26) | 23, 27 |
| 26 | 133.89, | CH | 6.476 | 10.9 (25), 15.1 (27) | 24, 28 |
| 27 | 132.42, | CH | 6.299 | 15.1(26), 11.0 (28) | 27, 29 |
| 28 | 133.90, | CH | 6.649 | 11.0 (27), 15.6 (29) | 7, 9, 26, 30 |
| 29 | 133.88, | CH | 6.630 | 15.6 (28), 10.9 (30) | 27, 31 |
| 30 | 133.25, | CH | 6.496 | 10.9 (29), 15.4 (31) | 28, 32 |
| 31 | 133.91, | CH | 6.673 | 15.4 (30), 11.3 (32) | 29, 33 |
| 32 | 133.01, | CH | 6.405 | 11.3 (31), 15.1 (33) | 30, 34 |
| 33 | 133.84, | CH | 6.624 | 15.1 (32), 11.0 (34) | 31, 35 |
| 34 | 132.49, | CH | 6.301 | 11.0 (33), 15.5 (35) | 2ab, 3, 32, 36 |
| 35 | 136.99, | CH | 5.598 | 15.5 (34), 9.3 (36) | 33, 36, 37, Me36 |
| 36 | 40.14, | CH | 2.542 | 9.3 (35), 9.2 (37), 6.8 (Me36) | 34, 35, 37, 39a, 39b, Me36, Me38 |
| 37 | 78.63, | CH | 5.080 | 9.2 (36), 2.9 (38) | 35, 36, 38, 39a, Me36, Me38 |
| 38 | 33.81, | CH | 1.927 | 2.9 (37), ? (39a, 39b) 2, 6.7 (Me38) | 37, 39a, 39b, 40ab, 41, Me36, Me38 |
| 39a | 30.84, | CH2 | A: 1.719 B: 1.714 | ? (38, 39b) 2, ? (40ab) 1 | 36, 37, 38, 39b, 40ab, 41, Me38 |
| 39b | A: 1.761 B: 1.757 | ? (38, 39a) 2, ? (40ab) 1 | 36, 37, 38, 39a, 40ab, 41, Me38 | ||
| 40ab 1 | A: 35.64, B: 35.66, | CH2 | A: 1.895 B: 1.877 | ? (39a, 39b, 41) 1 | 38, 39a, 39b, 41, 42a, 42b, Me38 |
| 41 | A: 68.35, B: 68.28, | CH | A: 4.609 B: 4.592 | ? (40ab)1, 3.5 (42a), 9.1 (42b) | 38, 39a, 39b, 40ab, 42a, 42b, 45/45′ |
| 42a | A: 46.11, B: 46.04, | CH2 | A: 3.233 B: 3.211 | 3.5 (41), 15.2 (42b) | 40ab, 41, 42b, 45/45′ |
| 42b | A: 3.435 B: 3.410 | 9.1 (41), 15.2 (42a) | 40ab, 41, 42a, 45/45′ | ||
| 43 | A: 197.76, B: 197.67, | C | – | – | – |
| Me36 | 16.48, | CH3 | 0.972 | 6.8 (36) | 35, 36, 37, 38 |
| Me38 | 12.91, | CH3 | 1.040 | 6.7 (38) | 36, 37, 38, 39a, 39b |
| COOMe | 173.91, | C | – | – | – |
| COOMe | 51.66, | CH3 | 3.818 | – | 2′, 3′ |
| NHMe | A: 29.36, B: –, | CH3 | A: 2.811 B: – | – | 46/46′ |
| Aromatic moiety | |||||
| 45/45′ | A: 131.05, B: 131.23, | CH | 8.161 | 8.6 (46/46′) | 41, 42a, 42b, 46/46′ |
| 46/46′ | A: 110.94, B: 110.24, | CH | 6.757 | 8.6 (45/45′) | 45/45′, NHMe |
| C*CO | A: 154.38, B: 154.25, | C | – | – | – |
| C*NH | A: 126.12, B: 126.64, | C | – | – | – |
| Mycosamine moiety | |||||
| 1′ | 98.16, | CH | 4.974 | 1.9 (2′) | 2′, 3′, 5′, 19, 20b, 21 |
| 2′ | 70.79, | CH | 4.444 | 1.9 (1′), 3.5 (3′) | 1′, 3′, 19, COOMe |
| 3′ | 56.09, | CH | 4.677 | 3.5 (2′), 9.4 (4′), 4.5 (NHCOMe) | 1′, 2′, 5′, COOMe, NHCOMe |
| 4′ | 74.62, | CH | 4.034 | 9.4 (3′), 9.5 (5′) | 6′, NHCOMe |
| 5′ | 74.69, | CH | 3.790 | 9.5 (4)’, 6.3 (6′) | 1′, 3′, 6′ |
| 6′ | 18.41, | CH3 | 1.591 | 6.3 (5′) | 4′, 5′ |
| NHCOMe | 22.83, | CH3 | 2.113 | – | 3′, NHCOMe |
| NHCOMe | 170.90, | C | – | – | – |
| NHCOMe | – | – | 8.850 | 4.5 (3′) | 4′, NHCOMe |
1 These protons were perfectly superimposed; hence, the values of the coupling constants involving protons 2a, 2b, 40a and 40b could not be measured. 2 These coupling constants could not be measured due to severe signal overlaps and higher order effects.
References
- Omura, S.; Tanaka, H. Macrolide Antibiotics. In Chemistry, Biology, Practice, 1st ed.; Omura, S., Ed.; Academic Press: London, UK, 1984. [Google Scholar]
- Borowski, E.; Schaffner, C.P. Structural Relationships among the Heptaene Macrolide Antibiotics. In Proceedings of the V International Congress of Biochemistry, Moscow, Russia, 10–16 August 1961; p. 3. [Google Scholar]
- Oroshnik, W.; Mebane, A.D. The Polyene Antifungal Antibiotics. Prog. Chem. Org. Nat. Prog. 1963, 21, 17–79. [Google Scholar] [CrossRef]
- Cybulska, B.; Ziminski, T.; Borowski, E.; Gary-Bobo, C.M. The influence of electric charge of aromatic heptaene macrolide antibiotics on their activity on biological and lipidic model membranes. Mol. Pharmacol. 1983, 24, 270–276. [Google Scholar] [PubMed]
- Szczeblewski, P.; Laskowski, T.; Kubacki, B.; Dziergowska, M.; Liczmańska, M.; Grynda, J.; Kubica, P.; Kot-Wasik, A.; Borowski, E. Analytical studies on ascosin, candicidin and levorin multicomponent antifungal antibiotic complexes. The stereostructure of ascosin A2. Sci. Rep. 2017, 7, 40158. [Google Scholar] [CrossRef] [PubMed]
- Golik, J.; Zielinski, J.; Borowski, E. The structure of mepartricin A and mepartricin B. J. Antibiot. 1980, 33, 904–907. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Tweit, R.C.; Pandey, R.C.; Rinehart, K.L., Jr. Characterization of the Antifungal and Antiprotozoal Antibiotic Partricin and Structural Studies on Partricins A and B. J. Antibiot. 1982, 35, 997–1012. [Google Scholar] [CrossRef] [Green Version]
- Sowinski, P.; Gariboldi, P.; Czerwinski, A.; Borowski, E. The structure of vacidin A, an aromatic heptaene macrolide antibiotic. I. Complete assignment of the 1H NMR spectrum and geometry of the polyene chromophore. J. Antibiot. 1989, 42, 1631–1638. [Google Scholar] [CrossRef] [Green Version]
- Sowinski, P.; Gariboldi, P.; Pawlak, J.K.; Borowski, E. The structure of vacidin A, an aromatic heptaene macrolide antibiotic. II. Stereochemistry of the antibiotic. J. Antibiot. 1989, 42, 1639–1642. [Google Scholar] [CrossRef] [Green Version]
- Sowiński, P.; Pawlak, J.; Borowski, E.; Gariboldi, P. Stereostructure of Gedamycin. Pol. J. Chem. 1995, 69, 213–217. [Google Scholar]
- Cirillo Marucco, E.; Pagliarulo, A.; Piccinno, A.; di Rienzo, U. Mepartricin in the Treatment of Benign Prostatic Hyperplasia. Minerva Urol. Nefrol. 1988, 40, 101–104. [Google Scholar]
- Boehm, S.; Nirnberger, G.; Ferrari, P. Estrogen Suppression as a Pharmacotherapeutic Strategy in the Medical Treat-ment of Benign Prostatic Hyperplasia: Evidence for Its Efficacy from Studies with Mepartricin. Wien. Klin. Wochenschr. 1998, 110, 817–823. [Google Scholar]
- Petrone, U.; Gaspari, G.; Magnocavallo, N.; Petrone, D.; Tucci, C.; Marascia, G. Use of mepartricin in the treatment of benign prostatic hypertrophy. Evaluation of clinical and functional parameters. Minerva Urol. Nefrol. 1988, 40, 89–91. [Google Scholar]
- De Rose, A.F.; Gallo, F.; Giglio, M.; Carmignani, G. Role of mepartricin in category III chronic nonbacterial prostatitis/chronic pelvic pain syndrome: A randomized prospective placebo-controlled trial. Urology 2004, 63, 13–16. [Google Scholar] [CrossRef]
- Lotti, T.; Mirone, V.; Prezioso, D.; de Bernardi, M.; Rapocci, M.P.; Ruozi, P. Observations on Some Hormone Fractions in Patients with Benign Prostatic Hyperplasia Treated with Mepartricin. Curr. Ther. Res. 1988, 44, 402–409. [Google Scholar]
- Szwarc, K.; Szczeblewski, P.; Sowiński, P.; Borowski, E.; Pawlak, J. The stereostructure of candicidin D. J. Antibiot. 2015, 68, 504–510. [Google Scholar] [CrossRef]
- Szczeblewski, P.; Laskowski, T.; Bałka, A.; Borowski, E.; Milewski, S. Light-Induced Transformation of the Aromatic Heptaene Antifungal Antibiotic Candicidin D into Its All-Trans Isomer. J. Nat. Prod. 2018, 81, 1540–1545. [Google Scholar] [CrossRef]
- Szczeblewski, P.; Andrałojć, W.; Polit, J.; Żabka, A.; Winnicki, K.; Laskowski, T. Ipertrofan revisited-The proposal of the complete stereochemistry of mepartricin A and B. Molecules 2021, 26, 5533. [Google Scholar] [CrossRef]
- Waksman, S.A.; Lechevalier, H.A.; Schaffner, C.P. Candicidin and other polyenic antifungal antibiotics. Bull. World Health Organ. 1965, 33, 219–226. [Google Scholar] [PubMed]
- Płosiński, M.; Laskowski, T.; Sowiński, P.; Pawlak, J. Stereostructure of mycoheptin A2. Magn. Reson. Chem. 2012, 50, 818–822. [Google Scholar] [CrossRef]
- Szwarc, K.; Szczeblewski, P.; Sowiński, P.; Borowski, E.; Pawlak, J. The structure, including stereochemistry, of levorin A1. Magn. Reson. Chem. 2015, 53, 479–484. [Google Scholar] [CrossRef] [PubMed]
- Borzyszkowska-Bukowska, J.; Szczeblewski, P.; Konkol, A.; Grynda, J.; Szwarc-Karabyka, K.; Laskowski, T. The complete stereochemistry of the antibiotic candicidin A3 (syn. ascosin A3, levorin A3). Nat. Prod. Res. 2019, 34, 2869–2879. [Google Scholar] [CrossRef] [PubMed]
- Sowinski, P.; Pawlak, J.; Borowski, E.; Gariboldi, P. 1H NMR model studies of amphotericin B: Comparison of x-ray and NMR stereochemical data. Magn. Reson. Chem. 1992, 30, 275–279. [Google Scholar] [CrossRef]
- Sowinski, P.; Pawlak, J.; Borowski, E.; Gariboldi, P. Stereostructure of Rimocidin. J. Antibiot. 1995, 48, 1288–1291. [Google Scholar] [CrossRef] [Green Version]
- Pawlak, J.; Sowiński, P.; Borowski, E.; Gariboldi, P. Stereostructure of Perimycin A. J. Antibiot. 1995, 48, 1034–1038. [Google Scholar] [CrossRef] [Green Version]
- Pawlak, J.; Sowinski, P.; Borowski, E.; Gariboldi, P. Stereostructure and NMR characterization of the antibiotic candidin. J. Antibiot. 1993, 46, 1598–1604. [Google Scholar] [CrossRef] [PubMed]
- Borzyszkowska-Bukowska, J.; Górska, J.; Szczeblewski, P.; Laskowski, T.; Gabriel, I.; Jurasz, J.; Kozłowska-Tylingo, K.; Milewski, S. Quest for the Molecular Basis of Improved Selective Toxicity of All-Trans Isomers of Aromatic Heptaene Macro-lide Antifungal Antibiotics. Int. J. Mol. Sci. in press.
- Borowski, E.; Ciechocka, K.; Dutkiewicz, M.; Zimiński, T. Sposób Otrzymywania Kandycydyny o Zwiększonej Trwałości, Czystości i Aktywności. Biologicznej. Patent No. 83710, 30 January 1976. [Google Scholar]
Figure 1.
Structure of partricins A and B, along with their methyl esters of N-acetyl derivatives.
Figure 2.
Superimposed HPLC–DAD–ESIMS chromatograms of partricin complex. Red line: sample dissolved and stored at room temperature for 24 h, with an unlimited access to daylight. Blue line: sample dissolved and stored at room temperature in darkness for 24 h (control).
Figure 2.
Superimposed HPLC–DAD–ESIMS chromatograms of partricin complex. Red line: sample dissolved and stored at room temperature for 24 h, with an unlimited access to daylight. Blue line: sample dissolved and stored at room temperature in darkness for 24 h (control).
Figure 3.
Structure of iso-partricins A and B, along with their methyl esters of N-acetyl derivatives. Dipolar couplings between the protons of the chromophores and the polyol chains are depicted as bidirectional arrows. Colors: blue—ROEs observed only for the native partricins [8,10]; green—ROEs observed for both native and isomeric partricins; red—ROEs observed only for the all-trans iso-partricins.
Figure 3.
Structure of iso-partricins A and B, along with their methyl esters of N-acetyl derivatives. Dipolar couplings between the protons of the chromophores and the polyol chains are depicted as bidirectional arrows. Colors: blue—ROEs observed only for the native partricins [8,10]; green—ROEs observed for both native and isomeric partricins; red—ROEs observed only for the all-trans iso-partricins.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
MDPI and ACS Style
Szczeblewski, P.; Górska, J.; Andrałojć, W.; Janke, P.; Wąsik, K.; Laskowski, T. Iso-Partricin, an Aromatic Analogue of Amphotericin B: How Shining Light on Old Drugs Might Help Create New Ones. Antibiotics 2021, 10, 1102. https://doi.org/10.3390/antibiotics10091102
AMA Style
Szczeblewski P, Górska J, Andrałojć W, Janke P, Wąsik K, Laskowski T. Iso-Partricin, an Aromatic Analogue of Amphotericin B: How Shining Light on Old Drugs Might Help Create New Ones. Antibiotics. 2021; 10(9):1102. https://doi.org/10.3390/antibiotics10091102
Chicago/Turabian StyleSzczeblewski, Paweł, Justyna Górska, Witold Andrałojć, Patryk Janke, Karolina Wąsik, and Tomasz Laskowski. 2021. "Iso-Partricin, an Aromatic Analogue of Amphotericin B: How Shining Light on Old Drugs Might Help Create New Ones" Antibiotics 10, no. 9: 1102. https://doi.org/10.3390/antibiotics10091102
APA StyleSzczeblewski, P., Górska, J., Andrałojć, W., Janke, P., Wąsik, K., & Laskowski, T. (2021). Iso-Partricin, an Aromatic Analogue of Amphotericin B: How Shining Light on Old Drugs Might Help Create New Ones. Antibiotics, 10(9), 1102. https://doi.org/10.3390/antibiotics10091102
Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.
